Covid-booster response hope for most vulnerable
A break in taking a common immune-suppressing drug could improve how well vaccines work, a trial suggests. …
The research team, from Nottingham, the University of Manchester, Imperial College London, the University of Oxford and Queen Mary University of London, now plan to measure T-cell responses – the part of the immune system that signals longer-lasting protection against severe disease – six months on.
About The Author
